In: International Journal of Legal Medicine, 2015, vol. 129, no. 1, p. 97-103
|
In: European Radiology, 2015, vol. 25, no. 8, p. 2222-2230
|
In: Human Reproduction, 2017, vol. 32, no. 4, p. 820-831
|
In: Diabetologia, 2015, vol. 58, no. 8, p. 1827-1835
|
In: Cancer Immunology, Immunotherapy, 2015, vol. 64, no. 8, p. 1033-1046
|
In: Annals of Surgical Oncology, 2015, vol. 22, no. 13, p. 4198-4203
|
In: Surgical Endoscopy, 2015, vol. 29, no. 12, p. 3618-3627
|
In: Cancer Immunology, Immunotherapy, 2015, vol. 64, no. 5, p. 635-644
|
In: Seminars in Immunopathology, 2015, vol. 37, no. 5, p. 519-528
|
In: Journal of Antimicrobial Chemotherapy, 2020, vol. 75, no. 12, p. 3593–3600
Background: Carbapenemase-producing Enterobacterales represent a major therapeutic challenge. MBLs, requiring zinc at their catalytic site, could be inhibited by meso-dimercaptosuccinic acid (DMSA), a heavy metal chelator already widely used for treating lead intoxication.Objectives: To evaluate the activity of carbapenems alone or combined with DMSA against MBL-producing Escherichia coli in...
|